US Patent 8158581 IGF-1 fusion polypeptides and therapeutic uses thereof
Patent 8158581 was granted and assigned to Regeneron Pharmaceuticals, Inc. on April, 2012 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 8158581 IGF-1 fusion polypeptides and therapeutic uses thereof
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
